Abstract:Objective To evaluate the transduction efficiency of the serotypes of adeno-associated virus(AAV)as vector for cochlear gene therapy,the otoprotective efficacy of AAV-mediated glial cell line-derivedneurotrophic factor(GDNF)gene on aminoglycoside-induced ototoxicity.Methods Seven serotypes of AAV(AAV1～5,7,8)harboring the enhanced green fluorescent protein(EGFP),and AAV1 vector encoding the mouseGDNF,were microinjected into the cochlea.The expression pattern of AAV-mediated EGFP was determined withfluorescence microscope and screening.The cochlear function was analyzed with evoked auditory brainstemresponses(ABR).The GDNF expression was detected with ELISA and histochemistry,and the cochlear ganglioncells and hair cells were checked for evaluation.Results Each of these serotypes successfully targetted distinctcell types within the cochlea.In contrast to other serotypes,AAV3 vector specifically and most efficientlytransduced the cochlear inner hair cells in vivo,while AAV1 could infect inner hair cells as well as other celltypes.GDNF level in the cochlear inoculated with AAV1-GDNF was higher than that in the controls,and GDNFexpression pattern in the cochlea was similar to AAV1-mediated EGFP expression.The ABR monitoring revealedthat the inoculated cochlea with AAV1-GDNF vector showed better ABR thresholds after exposure to theototoxins,as compared to the contralateral side.Fewer missing spiral ganglion cells and hair cells were foundin the inoculated cochlear,as compared with the controls.Conclusion The results demonstrated the feasibilityof gene therapy for cochlear application,and AAV1-mediated GDNF expression preserved the cochlear functionfrom the aminoglycosides-induced ototoxicity,suggested that AAV1-mediated expression of GDNF could bedeveloped as a valuable prevention against aminoglycoside-induced damage.

Effects of Adeno-Associated Virus Vector-Mediated GDNF Gene Transfer on Kanamycin-Induced Cochlear Toxicity